The Future of Genetic Therapy for Inherited Cardiomyopathy

This Viewpoint explores the potential for genetic therapies to treat inherited cardiomyopathies at the intersection of unmet clinical need, patient appetite, and technological advances.

Corresponding Author: Hugh Watkins, MD, PhD, John Radcliffe Hospital, Level 6, West Wing, Oxford OX3 9DU, United Kingdom (hugh.watkins@rdm.ox.ac.uk).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.